Intermountain Health And New Plans Will Redefine Value Care

Published
20 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$3.00
96.7% undervalued intrinsic discount
15 Aug
US$0.10
Loading
1Y
-97.2%
7D
-77.3%

Author's Valuation

US$3.0

96.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 17%

Shared on24 Apr 25
Fair value Increased 21%

AnalystConsensusTarget has decreased revenue growth from 68.4% to 58.2%, decreased profit margin from 10.3% to 5.6%, increased future PE multiple from 5.0x to 10.4x and decreased shares outstanding growth rate from 0.3% to 0.1%.